| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.39 | 0.07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |